XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 9,047,401 $ 7,507,659
Short-term investments available-for-sale, at fair value   4,304,901
Accounts receivable 3,159,223 1,377,441
Inventory, net of allowance of $186,475 at September 30, 2017 and $270,307 at December 31, 2016 1,250,763 1,511,053
Prepaid expenses and other 527,623 433,328
Total current assets 13,985,010 15,134,382
Deferred offering costs   49,630
Property and equipment, net 3,255,438 3,270,197
Total assets 17,240,448 18,454,209
Current liabilities:    
Accounts payable 2,693,238 761,663
Accrued liabilities 1,997,570 1,670,286
Deferred revenue - current 780,965 335,659
NuvoGen obligation - current 460,698 604,751
Term loan payable - current, net of discount and debt issuance costs of $103,738 at September 30, 2017 and $0 at December 31, 2016 7,363,662 6,389,782
Other current liabilities 228,779 258,850
Total current liabilities 13,524,912 10,020,991
Term loan payable - non-current, net of discount and debt issuance costs of $0 at September 30, 2017 and $263,378 at December 31, 2016   5,389,137
NuvoGen obligation - non-current, net of discount 7,709,162 8,017,356
Other non-current liabilities 523,315 619,587
Total liabilities 21,757,389 24,047,071
Commitments and Contingencies
Stockholders’ deficit:    
Common stock, $0.001 par value; 200,000,000 shares authorized at September 30, 2017 and December 31, 2016; 12,507,215 shares issued and outstanding, at September 30, 2017; 7,939,967 and 7,938,571 shares issued and outstanding, respectively, at December 31, 2016 12,506 7,938
Additional paid-in-capital 128,114,619 110,081,334
Treasury stock, no shares as of September 30, 2017 and 1,396 shares as of December 31, 2016   (75,000)
Accumulated other comprehensive loss   (1,090)
Accumulated deficit (132,644,066) (115,606,044)
Total stockholders’ deficit (4,516,941) (5,592,862)
Total liabilities and stockholders' deficit $ 17,240,448 $ 18,454,209